Home > Insider Trading > Regulus Therapeutics Inc.

Regulus Therapeutics Inc. (RGLS)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

1 - 10
Next >>

Regulus Therapeutics Inc. (NASDAQ:RGLS) Q3 2022 Earnings Call Transcript

Operator: Hello, and welcome to the Regulus Therapeutics Inc. Q3 2022 Earnings Conference Call. . I would now like to turn the conference over to Chief Financial Officer, Cris Calsada.

Keep Reading →

December 29th, 2022 - News Transcripts

13 Best Biotech Penny Stocks To Buy Now

In this article, we will be taking a look at the 13 best biotech penny stocks to buy now.

Keep Reading →

November 29th, 2022 - Hedge Funds News

5 Biotech Penny Stocks to Buy According to Reddit

In this article, we discuss the 5 biotech penny stocks to buy according to Reddit.

Keep Reading →

August 6th, 2021 - Hedge Funds News

5 Best One Dollar Stocks to Buy Now

Rockwell Medical, Inc. (NASDAQ: RMTI) ranks 5th on the list of 10 best one dollar stocks to buy now.

Keep Reading →

July 22nd, 2021 - Hedge Funds News

Is Regulus Therapeutics Inc (RGLS) A Good Stock To Buy?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.

Keep Reading →

June 30th, 2021 - Hedge Funds News

Should I Buy Regulus Therapeutics Inc (RGLS)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

November 29th, 2020 - Hedge Funds News

Hedge Funds Are Dumping Regulus Therapeutics Inc (RGLS)

How do we determine whether Regulus Therapeutics Inc (NASDAQ:RGLS) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend...

Keep Reading →

December 22nd, 2019 - Hedge Funds News

13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)

You can access the original SEC filing by clicking here.

Keep Reading →

July 24th, 2017 - Hedge Funds

13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

Keep Reading →

July 24th, 2017 - Hedge Funds